Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
Authors:
- Shuanghu Tiger YuanSYShuanghu Tiger Yuan
- Richard Kj BrownRBRichard Kj Brown
- Lujun ZhaoLZLujun Zhao
- Randall K Ten HakenRHRandall K Ten Haken
- Milton GrossMGMilton Gross
- Kemp B CeaseKCKemp B Cease
- Matt SchipperMSMatt Schipper
- Paul StantonPSPaul Stanton
- Jinming YuJYJinming Yu
- Feng-Ming Spring KongFKFeng-Ming Spring Kong
Open Access
- 27 January 2014
- journal article
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 37
Abstract
To study whether esophageal FDG activity changes by time of mid-course of fractionated radiotherapy (RT), and whether these changes are associated with radiation esophagitis in patients with non-small cell lung cancer (NSCLC). Fifty patients with stage I-III NSCLC were enrolled prospectively and, all received ≥60 Gy RT. FDG-PET/CT scans were acquired prior to, and during-RT after delivery of 45 Gy. Normalized standardized uptake values (NSUV), defined by the esophageal maximum SUV relative to intravascular background level in the aortic arch, were sampled in the esophagus at the level of the primary tumor, sternal notch, aortic arch, carina, and gastro-esophageal junction. Symptomatic radiation esophagitis was defined as an event. Compared to baseline, esophageal NSUV increased significantly during-RT at the level of the primary tumor (1.09 ± 0.05 vs.1.28 ± 0.06, p = 0.001), but did not change at other levels in the esophagus. 16 patients had radiation esophagitis events and these patients had significantly higher during-RT to baseline NSUV ratios than those without esophagitis (1.46 ± 0.12, 95% CI 1.20-1.71; vs. 1.11 ± 0.05, 95% CI 1.01-1.21, p = 0.002). Maximum esophageal dose (p = 0.029), concurrent chemotherapy (p = 0.022) and esophageal FDG PET NSUV ratio (during-RT to baseline, p = 0.007), were independent factors associated with esophagitis and area under curves (AUC) were 0.76, 0.70 and 0.78, respectively. Combining esophageal maximum dose and FDG PET NSUV Ratio at the tumor level increased AUC to 0.85 (p = 0.016). FDG uptake increased in esophagus during-RT and this increase may predict radiation esphagitis during later course of treatment.Keywords
This publication has 19 references indexed in Scilit:
- Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancerRadiotherapy and Oncology, 2013
- Toxicité œsophagienne de la radiothérapie : clinique, facteurs de risque et prise en chargeCancer/Radiothérapie, 2012
- Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapyJournal of Radiation Research, 2012
- Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) DatabaseClinical Lung Cancer, 2011
- A Pilot Study of [18F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to TreatmentJournal of Clinical Oncology, 2004
- Radiation-Induced Esophagitis on FDG PET ImagingClinical Nuclear Medicine, 2003
- Benign causes of 18-FDG uptake on whole body imagingSeminars in Nuclear Medicine, 1998